Hend Shubar

SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood–brain barriers

Hend Shubar, Sabrina Lachenmaier, Markus M. Heimesaat et al. · Journal of drug targeting · 2010 · 66 citations

Pharmacy, Pharmacology, Toxicology +17

First Molecular Epidemiological Study of Cutaneous Leishmaniasis in Libya

Ahmad Amro, Aisha Gashout, Hamida Al‐Dwibe et al. · PLoS neglected tropical diseases · 2012 · 55 citations · Full text

Veterinary Medicine, Dermatology, Infectious Diseases +17

The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis

Hend Shubar, Ildikò Rita Dunay, Sabrina Lachenmaier et al. · Journal of drug targeting · 2009 · 37 citations

Pharmacy, Biochemistry, Molecular Pharmaceutics +17

A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo

Hend Shubar, John P. Mayer, W. Hopfenmüller et al. · Journal of Antimicrobial Chemotherapy · 2008 · 19 citations · Full text

Pharmacy, Pharmacology, Toxicology +12